glp 1 for teens MedPage - Two insulin-dependent adolescents with type diabetes and obesity had metabolic improvements after starting a low-dose GLP-1 agent, a case series showed. https://www.medpagetoday.com/endocrinology/type1diabetes/121164 Long-term Success of GLP-1s Hinges

The defendant corporationslike Novo Nordiskhave until December 23, 2024, to file their initial expert reports

Your ability to prescribe weight-loss medications depends heavily on: As a physician, you have full prescriptive authority in all 50 states for FDA-approved weight-loss medications

In a recent FDA drug safety communication regarding SGLT-2 inhibitor-associated DKA, hypovolemia and acute renal impairment were listed as potential factors that may contribute to the development of a high anion gap metabolic acidosis

Optometrists should perform a baseline dilated comprehensive eye examination on patients who take these medications for any reason to determine their pre-existing level of DR and whether they have any risk factors for developing NAION

The FDA has not reviewed, approved, or stamped that specific compounded preparation for safety, effectiveness, or quality